Ataxia: Dominant https://greenmedinfo.com/taxonomy/term/71492/all en There is a trend toward a higher prevalence of antigliadin antibodies in patients with sporadic ataxia and dominant ataxia. https://greenmedinfo.com/article/there-trend-toward-higher-prevalence-antigliadin-antibodies-patients-sporadic- PMID:  Neurology. 2003 May 27 ;60(10):1674-5. PMID: 12771263 Abstract Title:  Prevalence of antigliadin antibodies in ataxia patients. Abstract:  We determined antigliadin antibodies in 95 ataxia patients and 73 controls. Antibodies were positive in 8% of the controls, 19% of patients with sporadic ataxia, 8% of patients with recessive ataxia, and 15% of patients with dominant ataxia. Statistical comparison using chi(2) statistics did not reveal significant differences between the groups. Although we found a trend toward a higher prevalence of antigliadin antibodies in patients with sporadic ataxia and dominant ataxia, our data do not support an association of ataxia with antigliadin antibodies. https://greenmedinfo.com/article/there-trend-toward-higher-prevalence-antigliadin-antibodies-patients-sporadic-#comments Ataxia: Dominant Ataxia: Sporadic Gliadin Neurotoxic Anti-Gliadin Antibodies Human Study Fri, 13 Apr 2012 17:08:26 +0000 greenmedinfo 74207 at https://greenmedinfo.com